| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.4M | +16.0% |
| Cost of Revenue | $6.9M | +14.8% |
| Gross Profit | $10.5M | +16.9% |
| R&D Expense | $100K | +0.0% |
| SG&A Expense | $27.7M | +55.1% |
| Operating Income | -$19.9M | -78.1% |
| Interest Expense | $1.4M | — |
| Pre-tax Income | -$21.2M | -90.6% |
| Net Income | -$21.2M | -90.1% |
| EPS (Basic) | -$2.07 | +6.8% |
| EPS (Diluted) | -$2.07 | +6.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.0M | -67.6% |
| Accounts Receivable | $1.6M | +267.7% |
| Current Assets | $4.4M | -41.3% |
| Total Assets | $25.2M | +64.6% |
| Current Liabilities | $18.1M | +263.1% |
| Long-term Debt | $753K | -37.3% |
| Total Liabilities | $26.7M | +264.3% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.3M | -20.3% |
| Capital Expenditures | $2.3M | +312.1% |
| Investing Cash Flow | -$7.5M | -1225.0% |
| Financing Cash Flow | $18.6M | +3.8% |
| Free Cash Flow | -$17.6M | -32.8% |
| -$1.5M |
| -118.7% |